• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now

    2/6/24 7:00:00 AM ET
    $ASPI
    $CIA
    $CRVO
    $DRMA
    Major Chemicals
    Industrials
    Life Insurance
    Finance
    Get the next $ASPI alert in real time by email

    MIAMI, Feb. 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 67th Emerging Growth Conference on February 7 & 8, 2024.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1

    February 7, 2024

    9:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    10:10

    Introduction

    10:15 - 10:45

    Peninsula Energy Ltd. (OTCQB:PENMF) (ASX: PEN)

    Keynote speaker: Wayne W. Heili, MD, CEO & Director

    10:50 - 11:20

    VCI Global, Limited (NASDAQ:VCIG)

    Keynote speaker: Marco Bacanello, Executive Director

    11:25 - 11:55

    Ideal Power, Inc. (NASDAQ:IPWR)

    Keynote speakers: Dan Brdar, President, CEO & Director, and Tim Burns, CFO

    12:00 - 12:30

    Myriad Uranium Corp. (CSE:M) (OTCQB:MYRUF) (FSE: C3Q)

    Keynote speaker: Thomas David Lamb, President, CEO, Company Secretary & Director

    12:35 - 1:05

    Dermata Therapeutics, Inc. (NASDAQ:DRMA)

    Keynote Speaker: Gerry Proehl, Founder, Chairman, President & CEO

    1:10 - 1:40

    Optimum Bank Holdings, Inc. (NASDAQ:OPHC)

    Keynote speaker: Moishe Gubin, Chairman of the Board. 

    1:45 - 2:15

    Humanetics Pharmaceuticals

    Keynote speaker: Ronald, J. Zenk, President and CEO

    2:20 – 2:50

    Regen Biopharma, Inc. (OTCQB:RGBP) (OTCQB:RGBPP)

    Keynote speakers: David Koos, President / CEO, Harry M. Lander, Ph.D. Senior Scientific Consultant, and Annette Marleau, PHD

    2:55 - 3:05

    Renforth Resources, Inc. (OTCQB:RFHRF) (CSE:RFR)

    Keynote speaker: Nicole Brewster, President & CEO

    3:10 - 3:20

    Patriot AG Corp

    Keynote speaker: Kyle Severson, COO

    3:25 - 3:35

    Helo Corp. (OTC:HLOC)

    Keynote speaker: Sean McVeigh, CEO & CFO

    3:40 - 3:50

    Starco Brands, Inc. (OTCQB:STCB)

    Keynote speaker: Ross Sklar, CEO

    3:55 - 4:05

    CerrvoMed Inc. (NASDAQ:CRVO)

    Keynote speaker: Dr. John Alam, CEO

    4:10 - 4:20

    Churchill Resources Inc (TSXV:CRI) (OTC:CRICF)

    Keynote speaker: Alec Rowlands, Corporate Consultant

    Postponed to March

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Gerald W. Shields, Vice Chairman and CEO, and Jeff Conklin, CFO

    4:40 – 4:50

    Glucotrack, Inc. (NASDAQ:GCTK)

    Keynote speaker: Paul Goode, CEO

    Day 2

    February 8, 2024

    9:20

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    9:40 - 10:10

    ANGLE plc (AIM: AGL) (OTCQX:ANPCY)

    Keynote speaker: Andrew Newland, Founder, CEO & Executive Director

    10:15 - 10:45

    Clearday, Inc. (OTCQX:CLRD)

    Keynote speakers: James Walesa, President / CEO & Chairman, and Dan Policy, Business Development Manager

    10:50 – 11:20

    22nd Century Group, Inc. (XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    11:25 - 11:55

    Atacama Resources International, Inc. (OTC:ACRL)

    Keynote speaker: Greg Praver IR

    12:00 - 12:30

    Maison Solutions Inc. (NASDAQ:MSS)

    Keynote speakers: John Xu, Chairman, President / CEO, and Chris Zhang, Vice President of Corporate Development & Strategy

    12:35 - 1:05

    ASP Isotopes, Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    1:10 - 1:40

    Energy Finders, Inc. (OTC:EGYF)

    Keynote speaker: Keith Pivonski, VP

    1:45 - 2:15

    Maritime Launch Services Inc. (OTCQB:MAXQF) (NEO: MAXQ)

    Keynote speaker: Stephen Matier, President / CEO

    2:20 – 2:50

    KORE Group Holdings, Inc. (NYSE KORE)

    Keynote speakers: Romil Bahl, President / CEO, Director & Paul Holtz, Executive VP, CFO

    2:55 - 3:05

    Intellicheck, Inc. (NASDAQ:IDN)

    Keynote speaker: Bryan Lewis, President, CEO & Director

    3:10 - 3:20

    CoTec Holding Corp - (OTCQB:CTHCF) (TSXV:CTH)

    Keynote speaker: Julian Treger, President / CEO

    3:25 - 3:35

    Pulsar Helium, Inc. (TSXV:PLSR)

    Keynote speaker: Thomas Abraham-James President / CEO

    3:40 - 3:50

    Battery Mineral Resources Corp. (OTCQB:BTRMF) (TSXV:BMR)

    Keynote speaker: Martin Kostuik, President / CEO

    3:55 - 4:05

    Ethema Health Corporation (OTC:GRST)

    Keynote speaker: Shawn Leon, Chairman, CEO, CFO

    4:10 – 4:20

    Electronic Servitor Publication Network Inc. (OTCQB:XESP)

    Keynote speaker: Peter Hager, President / CEO

    4:25 – 4:35

    Strawberry Fields REIT, Inc. (NYSE:STRW)

    Keynote speaker: Moishe Gubin, Chairman, CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ASPI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASPI
    $CIA
    $CRVO
    $DRMA

    CompanyDatePrice TargetRatingAnalyst
    CervoMed Inc.
    $CRVO
    12/18/2025Overweight
    Cantor Fitzgerald
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Intellicheck Inc.
    $IDN
    11/13/2025$7.00Market Perform → Outperform
    Northland Capital
    Strawberry Fields REIT Inc.
    $STRW
    10/1/2025$14.00Overweight
    Cantor Fitzgerald
    Strawberry Fields REIT Inc.
    $STRW
    7/2/2025$10.65Buy → Neutral
    Compass Point
    CervoMed Inc.
    $CRVO
    3/13/2025$14.00Neutral → Buy
    Chardan Capital Markets
    Strawberry Fields REIT Inc.
    $STRW
    1/16/2025$14.00Buy
    Compass Point
    Strawberry Fields REIT Inc.
    $STRW
    1/8/2025$13.50Buy
    Lake Street
    More analyst ratings

    $ASPI
    $CIA
    $CRVO
    $DRMA
    SEC Filings

    View All

    Ideal Power Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Ideal Power Inc. (0001507957) (Filer)

    3/10/26 10:32:50 AM ET
    $IPWR
    Semiconductors
    Technology

    ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASP Isotopes Inc. (0001921865) (Filer)

    3/10/26 8:22:22 AM ET
    $ASPI
    Major Chemicals
    Industrials

    SEC Form 6-K filed by VCI Global Limited

    6-K - VCI Global Ltd (0001930510) (Filer)

    3/9/26 10:31:15 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    $ASPI
    $CIA
    $CRVO
    $DRMA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ideal Power Reports Fourth Quarter and Full Year 2025 Financial Results

    AUSTIN, Texas, March 10, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, reports results for its fourth quarter and full year ended December 31, 2025."We're excited to have signed two new customer agreements for the development of B-TRAN®-enabled solutions addressing focus applications that span solid-state circuit protection for data centers, renewable energy and energy storage systems, grid, electric vehicles and charging infrastructure," said David Somo, President and Chief Executive Officer of Ideal Power. "We detailed the

    3/10/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    ASP Isotopes to Participate in Canaccord Genuity's 2nd Annual CG Virtual Sustainability Summit

    DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Paul Mann, Chief Executive Officer, will participate in a fireside chat at Canaccord Genuity's 2nd Annual CG Virtual Sustainability Summit on Thursday, March 12, 2026, at 3:20 p.m. ET. A live audio webcast of the presentation will be available in the Investors section of the Company's website at www.aspisotopes.com. A replay will be available on the Company's website within 48 hours after the event. About ASP Iso

    3/10/26 8:11:23 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Glucotrack to Present at LSI USA '26 Medtech Innovation Summit

    RUTHERFORD, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.("Glucotrack", or the "Company") (NASDAQ:GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Paul V. Goode, PhD, President and Chief Executive Officer, will present at LSI USA '26 Summit, taking place March 16-20, 2026, in Dana Point, California. The presentation will take place on Tuesday, March 17 at 8:15 a.m. PT. Dr. Goode will introduce Glucotrack's continuous blood glucose monitor (CBGM) technology, share its positive first-in-human study results, outline the Company's regulatory strategy and commercialization

    3/10/26 8:01:00 AM ET
    $GCTK
    Medical/Dental Instruments
    Health Care

    $ASPI
    $CIA
    $CRVO
    $DRMA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Somo David M bought $250,000 worth of shares (90,909 units at $2.75), increasing direct ownership by 37% to 338,347 units (SEC Form 4)

    4 - Ideal Power Inc. (0001507957) (Issuer)

    2/26/26 8:49:32 AM ET
    $IPWR
    Semiconductors
    Technology

    Chief Investment Officer Bajtner Jeffrey bought $18,746 worth of shares (1,431 units at $13.10), increasing direct ownership by 66% to 3,605 units (SEC Form 4)

    4 - Strawberry Fields REIT, Inc. (0001782430) (Issuer)

    1/29/26 4:05:36 PM ET
    $STRW
    Real Estate Investment Trusts
    Real Estate

    Chief Financial Officer Flamion Greg Curtis bought $18,746 worth of shares (1,431 units at $13.10), increasing direct ownership by 74% to 3,353 units (SEC Form 4)

    4 - Strawberry Fields REIT, Inc. (0001782430) (Issuer)

    1/29/26 4:05:28 PM ET
    $STRW
    Real Estate Investment Trusts
    Real Estate

    $ASPI
    $CIA
    $CRVO
    $DRMA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on CervoMed

    Cantor Fitzgerald initiated coverage of CervoMed with a rating of Overweight

    12/18/25 9:09:07 AM ET
    $CRVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on ASP Isotopes with a new price target

    Cantor Fitzgerald initiated coverage of ASP Isotopes with a rating of Overweight and set a new price target of $13.00

    12/4/25 8:40:44 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Intellicheck upgraded by Northland Capital with a new price target

    Northland Capital upgraded Intellicheck from Market Perform to Outperform and set a new price target of $7.00

    11/13/25 8:21:51 AM ET
    $IDN
    Computer Software: Prepackaged Software
    Technology

    $ASPI
    $CIA
    $CRVO
    $DRMA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO Ainscow Robert sold $45,894 worth of shares (8,438 units at $5.44), decreasing direct ownership by 0.55% to 1,537,817 units (SEC Form 4)

    4 - ASP Isotopes Inc. (0001921865) (Issuer)

    3/6/26 9:45:07 PM ET
    $ASPI
    Major Chemicals
    Industrials

    Executive Chairman Mann Paul Elliot increased direct ownership by 2% to 7,597,385 units (SEC Form 4)

    4 - ASP Isotopes Inc. (0001921865) (Issuer)

    3/2/26 9:50:08 PM ET
    $ASPI
    Major Chemicals
    Industrials

    President and CEO Somo David M bought $250,000 worth of shares (90,909 units at $2.75), increasing direct ownership by 37% to 338,347 units (SEC Form 4)

    4 - Ideal Power Inc. (0001507957) (Issuer)

    2/26/26 8:49:32 AM ET
    $IPWR
    Semiconductors
    Technology

    $ASPI
    $CIA
    $CRVO
    $DRMA
    Financials

    Live finance-specific insights

    View All

    Ideal Power to Host Fourth Quarter and Full Year 2025 Results Conference Call on March 10, 2026 at 10:00 AM Eastern Time

    AUSTIN, Texas, Feb. 27, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will hold a conference call on Tuesday, March 10, 2026 at 10:00 AM Eastern Time to discuss its results for the fourth quarter and full year ended December 31, 2025. A press release detailing these results will be issued prior to the call.Ideal Power management will host the conference call, followed by a question-and-answer period. Analysts and investors may pose questions for management during the live conference call on March 1

    2/27/26 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    Strawberry Fields REIT Announces Q1 2026 Cash Dividend of $0.16 per Common Share and Date for 2026 Annual Stockholder Meeting

    SOUTH BEND, Ind., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE:STRW) (the "Company") today announced that its Board of Directors declared a cash dividend on its common stock in the amount of $0.16 per share (the "Dividend"). The Dividend will be payable in cash on March 31, 2026, to stockholders of record as of the close of business on March 17, 2026. Annual Stockholder Meeting The Company's 2026 Annual Meeting of Stockholders will be held on Thursday, May 7, 2026, at 10:00 a.m. EST. Stockholders of record as of the close of business on Wednesday, April 1, 2026 will be entitled to receive notice of and to participate at the 2026 Annual Meeting of Stockholders. Th

    2/26/26 5:00:00 PM ET
    $STRW
    Real Estate Investment Trusts
    Real Estate

    Ideal Power Business Update Webcast Call on February 26, 2026

    AUSTIN, Texas, Feb. 24, 2026 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and provider of its innovative and widely patented B-TRAN® bidirectional semiconductor power switch, today announced management will conduct a business update webcast call on February 26, 2026 at 1:00 PM ET. The webinar will be led by David Somo, Chief Executive Officer, President, and Board Member of Ideal Power.There will be an allotted time for equity research analysts and investors to ask questions during the live conference call on February 26. Additionally, questions can be submitted HERE in advance of the conference call.Interested persons may acce

    2/24/26 4:28:00 PM ET
    $IPWR
    Semiconductors
    Technology

    $ASPI
    $CIA
    $CRVO
    $DRMA
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leader in Fluid Dynamics and Energy Technology, as its Chief Technology Officer

    DALLAS, March 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI") today announced that Quantum Leap Energy LLC ("QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has appointed Nate Salpeter, Ph.D. as its Chief Technology Officer. Dr. Salpeter is a recognized key opinion leader in the field of physics-constrained energy technology optimization, with more than 15 years of experience building computational frameworks, laser-based experimental methods, and first-of-kind engineering programs across nuclear energy and advanced thermal sys

    3/5/26 7:30:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, announces the appointment of Eric Francois to the Company's Board of Directors. "Eric's decades of financial, transactional and operational experience will make an immediate impact to CERo's board of directors," said Chris Ehrlich, Company Chairman and Chief Executive Officer. "Furthermore, his expertise in capital raising, M&A, and business development will be an impactful addition at this stage of our development." Mr. Francois is an executive with over 25

    2/17/26 8:00:00 AM ET
    $CERO
    $CRVO
    $SCYX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

    Company to submit Investigational Device Exemption (IDE) to FDA for novel CBGM technology in Spring 2026 Expanded clinical advisory team with appointment of pain management and medical technology expert, Usman Latif, MD, MBA Strengthened balance sheet, cash and cash equivalents expected to fund operations through March 2026, including long-term feasibility clinical trials and achievement of related milestones Rutherford, NJ, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today reported financial results

    11/13/25 4:05:00 PM ET
    $GCTK
    Medical/Dental Instruments
    Health Care

    $ASPI
    $CIA
    $CRVO
    $DRMA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by VCI Global Limited

    SC 13G - VCI Global Ltd (0001930510) (Subject)

    12/6/24 6:01:22 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Intellicheck Inc.

    SC 13G/A - Intellicheck, Inc. (0001040896) (Subject)

    11/15/24 7:00:49 AM ET
    $IDN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Dermata Therapeutics Inc.

    SC 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject)

    11/14/24 5:07:13 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care